Complex regional haemodynamic effects of anandamide in conscious rats

British Journal of Pharmacology

Volumn 135, Issue 8, 2002, Pages 1889-1896

  Gardiner, S M ^a   March, J E ^a   Kemp, P A ^a   Bennett, T ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

5 HT; AM 215; Anandamide; Azasetron; Haemodynamics

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ANANDAMIDE; ATROPINE; AZASETRON; CANNABINOID RECEPTOR ANTAGONIST; RIMONABANT; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; BRADYCARDIA; DOSE RESPONSE; DRUG EFFECT; HEMODYNAMICS; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION; VASODILATATION;

EID: 0036246870     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704649     Document Type: Article

References (25)

1. 2-selective adrenoceptor antagonist (ICI 118551)
2. 3 receptor antagonist
3. Systemic and portal hemodynamic effects of anandamide
4. 2-adrenoceptors in the regional haemodynamic responses to bradykinin in conscious rats
5. Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats
6. Regional haemodynamic responses to the cannabinoid agonist, WIN 55212-2, in conscious, normotensive rats, and in hypertensive, transgenic rats
7. Effects of the cannabinoid receptor antagonist, AM 251, on the cardiovascular responses to the cannabinoid receptor agonist, WIN 55212-2, and to anandamide, in conscious rats
8. 2-adrenoceptor involvement in the hindquarters vasodilator effects of WIN 55212-2, HU 210 and anandamide in conscious Sprague-Dawley rats
9. 1 receptors
10. Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM 251 to rodent brain cannabinoid receptors
11. Endocannabinoids and vascular function
12. Endocannabinoids as cardiovascular modulators
13. Cardiovascular effects of anandamide in anesthetised and conscious normotensive and hypertensive rats
14. 3-receptor antagonist, azasetron, in conscious rats
15. 3 receptor mechanisms in regulation of basal pancreatic secretion in conscious rats
16. Endocannabinoids
17. The endocannabinoid system as a target for therapeutic drugs
18. Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat
19. Mechanism of the hypotensive action of anandamide in anesthetized rats
20. 1 cannabinoid receptor in the hypotensive action of anandamide
21. 3 receptors
22. 1 receptors
23. G-nitro-L-arginine methyl ester in conscious, Long Evans rats
24. Capsaicin-sensitive sensory neurons are involved in the plasma-catecholamine response of rats to selective stressors
25. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide